The global diabetes drugs market value was USD 78.43 Billion in 2025, driven by the increasing prevalence of diabetes across the globe. The market is forecasted to grow at a CAGR of 5.30% during the forecast period of 2026-2035 to achieve a value of USD 131.45 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
5.3%
Value in USD Billion
2026-2035
*this image is indicative*
The Asia Pacific region accounts for a significant share of the global market as it has a large diabetic population, China alone has more than 120 million diabetic people, and the number does not seem to stop. The rising number of diabetes patients can be due to multiple reasons, such as changing lifestyles, unhealthy diet, overconsumption of junk food, and obesity, among others. Looking at the scenario, various companies are developing new and cost-effective alternatives, anti-diabetic drugs. They have started advertising their products and treatments to spread awareness about the same. In addition to favourable government reimbursement policies, increasing development for insulins and improving healthcare infrastructure are propelling the market for diabetic drugs.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing inclination toward junk foods is a major factor why people become diabetic. The lifestyle is becoming increasingly hectic, and the inclination toward junk and processed foods is constantly rising, which keeps the need for constant development in the medical field alive. New drugs, such as Canagliflozin and dapagliflozin, are getting approved for the treatment of diabetes, which opens up numerous opportunities for both new and established competitors in the global diabetic medications industry.
Diabetes is a disease that occurs when the blood sugar levels rise up to extremely high levels, affecting body functions and other disruptions in the body. It is a chronic disease, and the types can be divided into Type1 and Type2. Diabetes drugs are used to control the sugar level through oral administration of insulin in the main treatment.
Breakup by Drugs
Breakup by Diabetes Type
Breakup by Distribution Channel
Breakup by Region
The market growth is majorly driven by the increasing cases of diabetes every day around the world. The degrading lifestyle and eating habits like excessive sugar-based food consumption, which does not seem to improve, are major reasons of concern as they can transform into other disorders like obesity, liver problems, and diabetes, among others. The demand for insulin is rising due to the increasing cases and especially among the type 1 diabetics, as the intake is greater in them.
To combat this ongoing issue, governments are increasing their investment in R&D. Healthcare organisations and pharmaceutical manufacturers are increasingly collaborating with the government to develop new products and cost-effective methods to support a wider group of population. The number of diabetes care centres is aiding the growth of the diabetes drugs market. Technological advancements in the diabetes diagnostics devices, such as portable glucometers, make it possible for people to track their blood glucose levels, and the increasing availability of these devices will drive the growth of the market as when the people become aware of the situation, they will be more likely to get treatment, which simultaneously raises the market for diabetes drugs.
The report gives a detailed analysis of the following key players in the global diabetes drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Globally, Diabetes Drugs market reached a value of USD 78.43 Billion in 2025.
The market is projected to expand at a CAGR of 5.30% from 2026 to 2035, growing to USD 131.45 Billion by 2035.
The major drivers include the rapidly increasing diabetic population, rising investments in the R&D for better treatment, technological advancements, and the rising consumption of food with sugar, lack of exercise, and unhealthy diets.
The rising investment by the government in drug development is a key industry trend driving the market growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Asia Pacific accounting for the largest share of the market.
The types of drugs can be divided into oral anti-diabetic drugs and insulin. Oral anti-diabetic drugs can be further divided into Alpha-glucosidase inhibitors, Biguanides, Bile Acid Sequestrants, Dopamine-2 Agonists, DPP-4 inhibitors, Meglitinides, SGLT2 Inhibitors, Sulfonylureas, TZDs, and oral combination therapy. Insulin can be further divided into Insulin Glargine, Insulin Aspart, Human Insulin, and Biosimilar Insulin.
The types of diabetes can be divided into Type 1 and Type 2.
The different distribution channels include online, hospital, and retail pharmacies.
The major players in the industry are Novo Nordisk A/S, Sanofi-aventis Groupe, Merck & Co. Inc., Eli Lilly and Company., AstraZeneca plc, Takeda Pharmaceutical Company Limited., and Novartis AG, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drugs |
|
| Breakup by Diabetes Type |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share